Patents by Inventor Daniel Vis

Daniel Vis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250177420
    Abstract: The present invention relates to a combination therapy of an inhibitor of the Bel-2 family of proteins selected from navitoclax, venetoclax, A-1331852, AZD5991, or A-1155463, together with an aurora kinase inhibitor for use in a method of treatment of a cancer selected from breast, ovarian, pancreatic, or prostate cancer in a patient.
    Type: Application
    Filed: February 10, 2023
    Publication date: June 5, 2025
    Applicants: Genome Research Limited, Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis
    Inventors: Elizabeth Coker, Amy Emery, Mathew Garnett, Patricia Jaaks, Daniel Vis, Lodewyk Wessels
  • Publication number: 20250134878
    Abstract: The present invention relates to a combination therapy a CHEK1 inhibitor and a TOP1 inhibitor for use in a method of treatment of colorectal cancer in a patient.
    Type: Application
    Filed: February 10, 2023
    Publication date: May 1, 2025
    Applicants: Genome Research Limited, Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis
    Inventors: Elizabeth Coker, Mathew Garnett, Patricia Jaaks, Daniel Vis, Lodewyk Wessels
  • Publication number: 20250041293
    Abstract: The present invention relates to a combination therapy of an IGF1R inhibitor together with an Akt inhibitor for the treatment of cancer, such as colorectal cancer, ovarian cancer, and endometrial cancer.
    Type: Application
    Filed: February 10, 2023
    Publication date: February 6, 2025
    Applicants: Genome Research Limited, Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis
    Inventors: Elizabeth Coker, Amy Emery, Mathew Garnett, Patricia Jaaks, Howard Lightfoot, Jose Dianes Santos, Daniel Vis, Lodewyk Wessels, Daniel Zerbino